Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 0.00% is 100% above its 5-year average of -7.65%, near the high end of its 5-year range (-131.92%–17.60%).
As of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
-10.51%
NET PROFIT MARGIN AVG 5Y
-7.65%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
+100.00%
CURRENT VS 5Y AVG
+100.00%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 729 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Equillium, Inc.
Market Cap
$90.73M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-10.51%
5Y Avg
-7.65%
Market Cap
$90.42M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$91.33M
Net Profit Margin
-39.96%
TTM Avg
-45.40%
3Y Avg
-116.56%
5Y Avg
-242.44%
Market Cap
$90.13M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$89.34M
Net Profit Margin
2.57%
TTM Avg
-5.95%
3Y Avg
-14.59%
5Y Avg
-10.91%
Market Cap
$89.21M
Net Profit Margin
7051.24%
TTM Avg
-5065.26%
3Y Avg
-2532.63%
5Y Avg
-1688.42%
Market Cap
$92.20M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$93.28M
Net Profit Margin
-1.41%
TTM Avg
0.88%
3Y Avg
1.31%
5Y Avg
1.31%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Equillium, Inc. (EQ) | $90.73M | 0.00% | 0.00% | -10.51% | -7.65% |
| Neumora Therapeutics, Inc. Common Stock (NMRA)vs › | $90.42M | 0.00% | 0.00% | 0.00% | 0.00% |
| electroCore, Inc. (ECOR)vs › | $91.33M | -39.96% | -45.40% | -116.56% | -242.44% |
| PMV Pharmaceuticals, Inc. (PMVP)vs › | $90.13M | 0.00% | 0.00% | 0.00% | 0.00% |
| ImmuCell Corporation (ICCC)vs › | $89.34M | 2.57% | -5.95% | -14.59% | -10.91% |
| Rallybio Corporation (RLYB)vs › | $89.21M | 7051.24% | -5065.26% | -2532.63% | -1688.42% |
| Biomea Fusion, Inc. (BMEA)vs › | $92.20M | 0.00% | 0.00% | 0.00% | 0.00% |
| Park Dental Partners, Inc. Common Stock (PARK)vs › | $93.28M | -1.41% | 0.88% | 1.31% | 1.31% |
| CareCloud, Inc. (CCLD)vs › | $86.69M | 6.21% | 8.02% | -5.41% | -4.66% |
| Atara Biotherapeutics, Inc. (ATRA)vs › | $85.35M | -269.42% | -19.58% | -904.79% | -881.91% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | -131.92% |
| 2024-09-30 | -0.06% |
| 2024-06-30 | 3.38% |
| 2024-03-31 | -25.58% |
| 2023-12-31 | -25.43% |
| 2023-09-30 | -41.83% |
| 2023-06-30 | -36.64% |
| 2023-03-31 | -44.37% |
| 2022-12-31 | 17.60% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
